BIOMARIN PHARMACEUTICAL INC's ticker is and the CUSIP is 09061GAE1. A total of 46 filers reported holding BIOMARIN PHARMACEUTICAL INC in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $502,000 | -38.5% | 475,000 | -40.6% | 0.00% | – |
| Q1 2018 | $816,000 | -31.4% | 800,000 | -27.3% | 0.00% | – |
| Q4 2017 | $1,190,000 | -3.0% | 1,100,000 | 0.0% | 0.00% | – |
| Q3 2017 | $1,227,000 | +130.6% | 1,100,000 | +129.2% | 0.00% | – |
| Q2 2017 | $532,000 | +42.6% | 480,000 | +45.5% | 0.00% | – |
| Q1 2017 | $373,000 | +49.8% | 330,000 | +47.3% | 0.00% | – |
| Q2 2016 | $249,000 | -3.9% | 224,000 | 0.0% | 0.00% | – |
| Q1 2016 | $259,000 | -10.1% | 224,000 | 0.0% | 0.00% | – |
| Q4 2015 | $288,000 | -0.3% | 224,000 | 0.0% | 0.00% | – |
| Q3 2015 | $289,000 | -16.2% | 224,000 | 0.0% | 0.00% | -100.0% |
| Q2 2015 | $345,000 | +3.6% | 224,000 | 0.0% | 0.00% | – |
| Q1 2015 | $333,000 | +53.5% | 224,000 | +21.1% | 0.00% | – |
| Q4 2014 | $217,000 | +10.7% | 185,000 | 0.0% | 0.00% | – |
| Q3 2014 | $196,000 | +2.6% | 185,000 | 0.0% | 0.00% | – |
| Q2 2014 | $191,000 | -5.9% | 185,000 | 0.0% | 0.00% | – |
| Q1 2014 | $203,000 | +3.6% | 185,000 | 0.0% | 0.00% | – |
| Q4 2013 | $196,000 | – | 185,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|